These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 8994320
1. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Men Y, Gander B, Merkle HP, Corradin G. Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320 [Abstract] [Full Text] [Related]
2. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Rosas JE, Hernández RM, Gascón AR, Igartua M, Guzman F, Patarroyo ME, Pedraz JL. Vaccine; 2001 Aug 14; 19(31):4445-51. PubMed ID: 11483270 [Abstract] [Full Text] [Related]
3. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Mata E, Carcaboso AM, Hernández RM, Igartua M, Corradin G, Pedraz JL. Vaccine; 2007 Jan 15; 25(5):877-85. PubMed ID: 17070628 [Abstract] [Full Text] [Related]
4. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR. Vaccine; 1997 Nov 15; 15(16):1716-23. PubMed ID: 9364673 [Abstract] [Full Text] [Related]
5. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Rosas JE, Pedraz JL, Hernández RM, Gascón AR, Igartua M, Guzmán F, Rodríguez R, Cortés J, Patarroyo ME. Vaccine; 2002 Mar 15; 20(13-14):1707-10. PubMed ID: 11906756 [Abstract] [Full Text] [Related]
6. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Audran R, Peter K, Dannull J, Men Y, Scandella E, Groettrup M, Gander B, Corradin G. Vaccine; 2003 Mar 07; 21(11-12):1250-5. PubMed ID: 12559806 [Abstract] [Full Text] [Related]
7. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid. Gupta RK, Chang AC, Griffin P, Rivera R, Siber GR. Vaccine; 1996 Oct 07; 14(15):1412-6. PubMed ID: 8994315 [Abstract] [Full Text] [Related]
8. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice. Jung T, Koneberg R, Hungerer KD, Kissel T. Int J Pharm; 2002 Mar 02; 234(1-2):75-90. PubMed ID: 11839439 [Abstract] [Full Text] [Related]
9. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Eldridge JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM. Infect Immun; 1991 Sep 02; 59(9):2978-86. PubMed ID: 1879922 [Abstract] [Full Text] [Related]
10. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC). Udhayakumar V, Saekhou A, Fang S, Jue D, Wohlhueter RM, Lal AA. Vaccine; 1998 Sep 02; 16(9-10):982-8. PubMed ID: 9682348 [Abstract] [Full Text] [Related]
11. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique. Frangione-Beebe M, Rose RT, Kaumaya PT, Schwendeman SP. J Microencapsul; 2001 Sep 02; 18(5):663-77. PubMed ID: 11508771 [Abstract] [Full Text] [Related]
12. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Men Y, Tamber H, Audran R, Gander B, Corradin G. Vaccine; 1997 Sep 02; 15(12-13):1405-12. PubMed ID: 9302752 [Abstract] [Full Text] [Related]
13. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Alonso MJ, Gupta RK, Min C, Siber GR, Langer R. Vaccine; 1994 Mar 02; 12(4):299-306. PubMed ID: 8178550 [Abstract] [Full Text] [Related]
14. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vordermeier HM, Coombes AG, Jenkins P, McGee JP, O'Hagan DT, Davis SS, Singh M. Vaccine; 1995 Nov 02; 13(16):1576-82. PubMed ID: 8578845 [Abstract] [Full Text] [Related]
17. Influence of adjuvants in inducing immune responses to different epitopes included in a multiepitope, multivalent, multistage Plasmodium falciparum candidate vaccine (FALVAC-1) in outbred mice. Rafi-Janajreh A, Tongren JE, Kensil C, Hackett C, Candal F, Lal A, Udhayakumar V. Exp Parasitol; 2002 May 02; 101(1):3-12. PubMed ID: 12243733 [Abstract] [Full Text] [Related]
18. Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines. Ertl HC, Varga I, Xiang ZQ, Kaiser K, Stephens L, Otvos L. Vaccine; 1996 Jun 02; 14(9):879-85. PubMed ID: 8843629 [Abstract] [Full Text] [Related]
19. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V. J Mol Recognit; 1993 Jun 02; 6(2):81-94. PubMed ID: 7508238 [Abstract] [Full Text] [Related]
20. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H. Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134 [Abstract] [Full Text] [Related] Page: [Next] [New Search]